Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-25 @ 2:50 AM
NCT ID: NCT04937933
Eligibility Criteria: Inclusion Criteria: * Trauma developed in less than 24 hours. * Presence of rib fractures below 3 (6). * Rib fractures being limited to a single hemithorax. * Having a visual analog scale (VAS) score of 5 or more. Exclusion Criteria: * Inability to provide informed consent (altered mental state, non-Turkish-speaking). * Patients with chest injury scores above 11 were excluded from the study because of the insufficiency of this multimodal treatment. * Having additional trauma-related injuries (including lung contusion, pneumothorax, hemothorax, etc.), skin lesions at the site of trauma, and/or trauma-related pain in multiple regions of the thorax. * Patients with fractures in ribs 1 and 2 (in terms of the risk of serious injury that may accompany). * History of regular analgesic usage (such as chronic pain syndrome, rheumatoid arthritis, osteoarthritis), antiaggregant and anticoagulant drug usage, and/or allergy to nonsteroidal antiinflammatory drugs (NSAID) and narcotic analgesics. * History of having coagulation disorders, hematologic disease, gastrointestinal bleeding, uncontrolled heart failure, chronic renal failure, chronic liver failure, and chronic lung disease. * Patients in whom trauma-related complications developed during the ED follow-up, the general condition worsened, vital signs were unstable, and patients that needed to be hospitalized.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 65 Years
Study: NCT04937933
Study Brief:
Protocol Section: NCT04937933